Jeffrey T L Smith - EVP & Chief Medical Officer at Zymeworks Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP & Chief Medical Officer
Stock Symbol
ZYME on Nasdaq
All Insider Reports
All Insider Reports

Jeffrey T L Smith - trading volume in the past year for Zymeworks Inc.

Holdings reported by Jeffrey T L Smith for Zymeworks Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Unit 53K $791K $14.92 Jan 10, 2025 Direct Common Stock
Common Stock 8.89K $133K $14.92 Jan 6, 2025 Direct
Stock Option (Right to Buy) 79K Jan 10, 2025 Direct Common Stock

Transactions reported by Jeffrey T L Smith for Zymeworks Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.